Literature DB >> 31900909

The Tumor Microenvironments of Lethal Prostate Cancer.

William L Harryman1, Noel A Warfel1, Raymond B Nagle2, Anne E Cress3.   

Abstract

Localized prostate cancer (confined to the gland) generally is considered curable, with nearly a 100% 5-year-survival rate. When the tumor escapes the prostate capsule, leading to metastasis, there is a poorer prognosis and higher mortality rate, with 5-year survival dropping to less than 30%. A major research question has been to understand the transition from indolent (low risk) disease to aggressive (high risk) disease. In this chapter, we provide details of the changing tumor microenvironments during prostate cancer invasion and their role in the progression and metastasis of lethal prostate cancer. Four microenvironments covered here include the muscle stroma, perineural invasion, hypoxia, and the role of microvesicles in altering the extracellular matrix environment. The adaptability of prostate cancer to these varied microenvironments and the cues for phenotypic changes are currently understudied areas. Model systems for understanding smooth muscle invasion both in vitro and in vivo are highlighted. Invasive human needle biopsy tissue and mouse xenograft tumors both contain smooth muscle invasion. In combination, the models can be used in an iterative process to validate molecular events for smooth muscle invasion in human tissue. Understanding the complex and interacting microenvironments in the prostate holds the key to early detection of high-risk disease and preventing tumor invasion through escape from the prostate capsule.

Entities:  

Mesh:

Year:  2019        PMID: 31900909     DOI: 10.1007/978-3-030-32656-2_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

1.  Integrins and Epithelial-Mesenchymal Cooperation in the Tumor Microenvironment of Muscle-Invasive Lethal Cancers.

Authors:  William L Harryman; Kendra D Marr; Ray B Nagle; Anne E Cress
Journal:  Front Cell Dev Biol       Date:  2022-03-01

2.  Bioactivity improvement via display of the hydrophobic core of HYD1 in a cyclic β-hairpin-like scaffold, MTI-101.

Authors:  Priyesh Jain; David B Badger; Yi Liang; Anthony W Gebhard; Daniel Santiago; Philip Murray; Sridhar R Kaulagari; Ted J Gauthier; Rajesh Nair; MohanRaja Kumar; Wayne C Guida; Lori A Hazlehurst; Mark L McLaughlin
Journal:  Pept Sci (Hoboken)       Date:  2020-10-09

3.  A Humanized Monoclonal Antibody Targeting Extracellular Nicotinamide Phosphoribosyltransferase Prevents Aggressive Prostate Cancer Progression.

Authors:  Belinda L Sun; Lin Tang; Xiaoguang Sun; Alexander N Garcia; Sara M Camp; Edwin Posadas; Anne E Cress; Joe G N Garcia
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.